Knowledge is our drug
IPS Therapeutique is a CRO dedicated to the preclinical evaluation of the efficacy and safety of new drugs using validated and highly predictive models in the following areas.
Efficacy testing often uses custom-made study designs, aiming at demonstrating the mitigation of the symptoms of clinical diseases in cellular and animal models. Robust results benefit the sponsor’s development team and shape the development strategy.
Lack of efficacy remains the first cause of failure in clinical development. The second cause of failure is unforeseen adverse effects. As experts in asset de-risking, IPST’s emphasis is fixed firmly on these two areas of drug development as part of preclinical research. Study outcomes are generally inserted directly into regulatory applications.
